Skip to content

PHARMANJE

Absorbed by MULTIPHARMA on 21-12-2016 KBO/BCE: BE 0808.848.653

Annual accounts 2015

abbreviated format, filed on 29-03-2016, 32 days before the deadline
€253,160
▲ 8.1%
€111,433
▲ 32.5%
€72,502
▲ 37.0%
-€100,152
▲ €123,962
33.5%
▲ 15.9 percentage points
0.70
▲ 0.18

Turnover is estimated at about €600,000, probably between €360,000 and €1.0m. The abbreviated format does not state turnover.

Balance sheet

balance sheet total €521,608 on 30-09-2015
What the company ownsHow it is paid for

in euro

in euro

Staff

€42,233

Staff costs divided by the average number of full-time equivalents.

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend201520142013201220112010
165,689146,986137,101124,57688,967158,833
126,757115,786116,349116,03975,354134,932
37151824,2427,0766,094783,733
-11,475-2,35134,169-33,558-17,674-
-100,152-224,114-338,642-434,768-540,807-595,749
33.5%17.6%7.6%2.9%-1.7%-0.5%
0.700.520.420.340.310.30
0.360.290.230.150.170.19
1.994.6912.2433.06--
41.5%51.9%59.0%164.3%--
13.9%9.1%4.5%4.8%-1.2%-3.3%

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend201520142013201220112010
Balance sheet: assets
20/58 521,608580,906650,307686,070784,153870,416
21/28 283,951337,835400,180463,315541,583619,872
21 139,979183,050226,120269,191312,261355,331
22/27 143,972154,785174,060194,124229,322264,540
22 132,627137,184142,034147,198152,694158,545
23 1736019492,0172,2211,995
24 11,17217,00031,07644,91074,407104,000
29/58 237,657243,072250,128222,755242,570250,544
3 117,076107,580114,611124,436106,06485,591
30/36 117,076107,580114,611124,436106,06485,591
40/41 58,10956,72653,99156,13454,59970,995
40 58,10956,57553,37454,29754,56869,828
41 -1516161,837311,167
54/58 61,33272,80775,15840,98974,54792,221
490/1 1,1415,9586,3681,1977,3601,737
Balance sheet: equity and liabilities
10/49 521,608580,906650,307686,070784,153870,416
10/15 174,541102,03949,11720,145-12,957-3,929
10/11 25,00025,00025,00025,00025,00025,000
100 25,00025,00025,00025,00025,00025,000
13 149,54177,03924,117---
130 2,5002,5002,500---
133 147,04174,53921,617---
14 ----4,855-37,957-28,929
17/49 347,067478,867601,191665,925797,110874,345
42/48 337,810467,186588,770657,523783,376846,294
42 -75,000150,000225,000--
43 ----300,000375,000
430/8 ----300,000375,000
44 149,193137,518149,411147,734205,511179,034
440/4 149,193137,518149,411147,734205,511179,034
45 19,37312,60913,1257,7579,53047,389
450/3 7,1964008271721,23218,907
454/9 12,17812,20912,2997,5858,29828,481
47/48 169,244242,059276,234277,032268,335244,871
492/3 9,25711,68112,4218,40213,73428,051
Income statement
76A ---1,593--
9900 253,160234,196220,957196,347170,392296,807
62 84,46584,69680,61369,49779,437134,320
630 54,25562,86387,37782,93784,382163,861
640/8 3,0062,5143,2432,2741,9883,655
9901 111,43384,12449,72441,6404,585-5,028
75/76B 3,4554,0114,1211,6324,08411,242
75 3,4554,0114,1211,6324,08411,242
65/66B 9,46812,34013,35311,71217,69835,143
65 9,46812,34013,35311,71217,69835,143
9903 105,42075,79540,49233,152-9,028-28,929
67/77 32,91822,87211,52051--
9904 72,50252,92328,97233,102-9,028-28,929
9905 72,50252,92328,97233,102-9,028-28,929
Appropriation of the result
9906 72,50252,92324,117-4,855-37,957-28,929
691/2 72,50252,92324,117---
6920 --2,500---
6921 72,50252,92321,617---
Social balance sheet
9087 2221.822
Hours worked1013 3,4963,5284,4923,1833,5865,933
Document PDFPDFPDFPDFPDFPDF

Source: Annual accounts 2015 (PDF), filed on 29-03-2016.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-09-2015 abbreviated format 29-03-2016 2016-07200515 PDF
30-09-2014 abbreviated format 30-03-2015 2015-07600060 PDF
30-09-2013 abbreviated format 03-04-2014 2014-08200497 PDF
30-09-2012 abbreviated format 30-04-2013 2013-11100112 PDF
30-09-2011 abbreviated format 02-04-2012 2012-07600014 PDF
30-09-2010 abbreviated format 01-04-2011 2011-07800350 PDF

Insights on PHARMANJE

The operating result for 2015 is 32% higher than in 2014 and the highest since 2010. It is the fifth rise in a row.

Debt's share of the balance-sheet total falls from 82.4% to 66.5%. Equity is higher and debt is lower.